Urokinase receptor-dependent and -independent p56/59hck activation state is a molecular switch between myelomonocytic cell motility and adherence

被引:57
作者
Chiaradonna, F
Fontana, L
Iavarone, C
Carriero, MV
Scholz, G
Barone, MV
Stoppelli, MP
机构
[1] CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy
[2] Ist Nazl Tumori, I-80131 Naples, Italy
[3] Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia
[4] European Mol Biol Lab, D-69012 Heidelberg, Germany
关键词
cell motility and adhesion; cytoskeleton; myelomonocytic differentiation; Src kinases; urokinase receptor signalling;
D O I
10.1093/emboj/18.11.3013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anchorage-independent myelomonocytic cells acquire adherence within minutes of differentiation stimuli, such as the proteolytically inactive N-terminal fragment of urokinase binding to its cognate glycosylphosphatidylinositol (GPI)-anchored receptor, Here, we report that urokinase-treated differentiating U937 monocytelike cells exhibit a rapid and transient inhibition of p56/59(hck) and p55(fgr) whereas no changes in the activity of other Src family kinases, such as p53/56(lyn) and p59(fyn) were observed. U937 transfectants expressing a kinase-defective (Lys267 to Met) p56/59(hck) variant exhibit enhanced adhesiveness and a marked F-actin redistribution in thin protruding structures. Conversely, urokinase as well as expression of wild-type or constitutively active (Tyr499 to Phe) p56/59(hck) stimulates the directional migration of uninduced U937 cells. Accordingly, expression of constitutively active or kinase inactive p56/59(hck) selectively prevents urokinase receptor-dependent induction of either adhesion or motility, indicating that a specific activation state of p56/59(hck) is required for each cell response. In conclusion, modulation of the intracellular p56/59(hck) tyrosine kinase activity switches cell motility towards adherence, providing a mutually exclusive mechanism to regulate these properties during monocyte/macrophage differentiation in vivo.
引用
收藏
页码:3013 / 3023
页数:11
相关论文
共 47 条
[1]   THE HUMAN P50(CSK) TYROSINE KINASE PHOSPHORYLATES P56(LCK) AT TYR-505 AND DOWN REGULATES ITS CATALYTIC ACTIVITY [J].
BERGMAN, M ;
MUSTELIN, T ;
OETKEN, C ;
PARTANEN, J ;
FLINT, NA ;
AMREIN, KE ;
AUTERO, M ;
BURN, P ;
ALITALO, K .
EMBO JOURNAL, 1992, 11 (08) :2919-2924
[2]   uPA, uPAR, PAI-I: key intersection of proteolytic, adhesive and chemotactic highways? [J].
Blasi, F .
IMMUNOLOGY TODAY, 1997, 18 (09) :415-417
[3]   UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR, BETA-2-INTEGRINS, AND SRC-KINASES WITHIN A SINGLE RECEPTOR COMPLEX OF HUMAN MONOCYTES [J].
BOHUSLAV, J ;
HOREJSI, V ;
HANSMANN, C ;
STOCKL, J ;
WEIDLE, UH ;
MAJDIC, O ;
BARTKE, I ;
KNAPP, W ;
STOCKINGER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1381-1390
[4]  
CARRIERO MV, 1994, CANCER RES, V54, P5445
[5]   Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration [J].
Chapman, HA .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (05) :714-724
[6]  
COLLINS SJ, 1987, BLOOD, V70, P1233
[7]   FACS-optimized mutants of the green fluorescent protein (GFP) [J].
Cormack, BP ;
Valdivia, RH ;
Falkow, S .
GENE, 1996, 173 (01) :33-38
[8]   THE UROKINASE RECEPTOR - PROTEIN-STRUCTURE AND ROLE IN PLASMINOGEN ACTIVATION AND CANCER INVASION [J].
DANO, K ;
BEHRENDT, N ;
BRUNNER, N ;
ELLIS, V ;
PLOUG, M ;
PYKE, C .
FIBRINOLYSIS, 1994, 8 :189-203
[9]  
DURDEN DL, 1995, J IMMUNOL, V154, P4039
[10]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR - NEW TARGETS FOR ANTIMETASTATIC THERAPY [J].
FAZIOLI, F ;
BLASI, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (01) :25-29